Moreover, knockdown of HEG1 markedly overcame the OXA resistance induced by PRMT3 OE in HepG2 cells in vivo as shown by weekly measurement of tumor volumes and tumor weights at the endpoint (Fig. 6j, k; Supplementary Fig. 7g). This evidence concerns the gene PRMT3 and neoplasm.